PRESCRIBED FOR: Repaglinide is used for treating type 2 diabetes in conjunction with diet and exercise. It can be used alone (monotherapy) or combined with metformin (Glucophage), pioglitazone (Actos), or rosiglitazone (Avandia).
SIDE EFFECTS: Hypoglycemia (low blood glucose) is the most frequent side effect and it occurs somewhat less frequently with repaglinide than with sulfonylureas such as glyburide and glipizide. Some symptoms of hypoglycemia include:
- heart palpitations,
- numbness around the mouth,
- tingling in the fingers,
- muscle weakness,
- blurred vision,
- cold temperature,
- excessive yawning,
- confusion, or
- loss of consciousness.
Quick GuideDiabetes Diet: Healthy Meal Plans for Diabetes-Friendly Eating
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.